Roche Glycart
Provider of in vitro diagnostics and provide transformative solutions for key therapeutic areas.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | N/A | Acquisition | |
| Total Funding | 000k | ||
Deutsche Venture Capital(exited)
Novartis Venture Fund(exited)
Forbion Capital Partners(exited)
Gilde Healthcare(exited)
Global Life Science Ventures(exited)
Quest Capital Management(exited)
BioMed Partners(exited)
ETH Zurich(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.